加载中
AMEXHealthcareMedical - Instruments & Supplies
最新数据
US$1.06
−US$0.08 · -7.02%
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
收盘时
US$1.06
−US$0.08 · -7.02%
盘后
US$1.10
+US$0.04 · +3.77%
10月13日 19:55 ET
盘中时间采用ET。市场数据可能有所延迟。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日内区间
当前US$1.06
52周区间
当前US$1.06
盘中时间采用ET。市场数据可能有所延迟。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日内区间
当前US$1.06
52周区间
当前US$1.06
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3237.7万 USD | 2691.8万 USD | 2677.1万 USD | 2814.7万 USD | 3502.1万 USD |
| 销货成本 | 1530.6万 USD | 1232.4万 USD | 1191.1万 USD | 967.7万 USD | 1178.9万 USD |
| 毛利 | 1707.1万 USD | 1459.4万 USD | 1486万 USD | 1847万 USD | 2323.2万 USD |
| 研究与开发 | 938.3万 USD | 976万 USD | 1027.3万 USD | 1055.8万 USD | 1019.9万 USD |
| 销售、一般及管理费用 | 3029.2万 USD | 2957.3万 USD | 2642.6万 USD | 2668.8万 USD | 2592.1万 USD |
| 营业费用 | 3918.3万 USD | 3933.3万 USD | 3669.9万 USD | 3724.6万 USD | 3612万 USD |
| 利息收入 | 46.7万 USD | 69.4万 USD | 109.6万 USD | 48.4万 USD | — |
| 利息支出 | — | — | — | — | 1.01万 USD |
| 折旧和摊销 | 155.5万 USD | 96.9万 USD | 59.5万 USD | 42.9万 USD | 10.6万 USD |
| 营业利润 | −2211.2万 USD | −2473.9万 USD | −2183.9万 USD | −1877.6万 USD | −1288.8万 USD |
| 净利润 | −2164.3万 USD | −2404.5万 USD | −2071.3万 USD | −1829.2万 USD | −1071.6万 USD |
公司数据更新于 2026年10月14日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$3.50
上涨空间 230.19%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2013年11月4日 | 137:125 | — | — |
股票拆分 | 2012年7月11日 | 1:10 | — | — |
已生效 2013年11月4日
137:125
已生效 2012年7月11日
1:10
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI285.65万0.00%2.3万亿 USD0.03%US$381.32-0.07%
iShares Russell 2000 ETFIWM185.47万0.00%777.48亿 USD0.19%US$276.7-0.43%
Vanguard Extended Market ETFVXF141.91万0.00%954亿 USD0.05%US$232.54-0.42%
iShares Russell 2000 Growth ETFIWO72.71万0.01%137.9亿 USD0.24%US$351.1-0.74%
Vanguard Russell 2000 ETFVTWO56.24万0.00%180亿 USD0.06%US$111.77-0.45%
iShares Micro-Cap ETFIWC24.68万0.02%13.07亿 USD0.60%US$179.6-1.13%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM14万0.12%1.16亿 USD0.73%US$15.6501-1.25%
Vanguard Russell 2000 Growth ETFVTWG11.09万0.01%17亿 USD0.06%US$256.21-0.80%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMVanguard Russell 2000 Growth ETFVTWGAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
